Literature DB >> 17869468

Recurrent attacks of status epilepticus as predominant symptom in 3-methylcrotonyl-CoA carboxylase deficiency.

Eray Dirik1, Uluç Yiş, Güven Paşaoğlu, Céline Chambaz, Matthias R Baumgartner.   

Abstract

A patient with isolated 3-methylcrotonyl-CoA carboxylase (MCC) deficiency with an unusual clinical presentation is described. The patient presented with clusters of seizures with two or three months disease free interval in the first year of life which then evolved into attacks of status epilepticus after the age of 12 months. MCC deficiency was suspected because of elevated C5-OH-carnitine in tandem mass spectrometry and elevated 3-hydroxy-isovaleric acid in urine organic acid analysis. Deficiency of MCC was confirmed in cultured fibroblasts and mutation analysis revealed a novel mutation in MCCB, p.S39F. Attacks of status epilepticus as a predominant symptom have not been described before in isolated MCC deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17869468     DOI: 10.1016/j.braindev.2007.08.005

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

1.  Neurochemical evidence that the metabolites accumulating in 3-methylcrotonyl-CoA carboxylase deficiency induce oxidative damage in cerebral cortex of young rats.

Authors:  Ângela Zanatta; Alana Pimentel Moura; Anelise Miotti Tonin; Lisiane Aurélio Knebel; Mateus Grings; Vannessa Araújo Lobato; César Augusto João Ribeiro; Carlos Severo Dutra-Filho; Guilhian Leipnitz; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2012-09-28       Impact factor: 5.046

2.  Is L-Carnitine Supplementation Beneficial in 3-Methylcrotonyl-CoA Carboxylase Deficiency?

Authors:  Jákup Andreas Thomsen; Allan Meldgaard Lund; Jess Have Olesen; Magni Mohr; Jan Rasmussen
Journal:  JIMD Rep       Date:  2015-03-03

3.  3-Methylcrotonylglycine disrupts mitochondrial energy homeostasis and inhibits synaptic Na(+),K (+)-ATPase activity in brain of young rats.

Authors:  Alana Pimentel Moura; César Augusto João Ribeiro; Ângela Zanatta; Estela Natacha Brandt Busanello; Anelise Miotti Tonin; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2011-10-13       Impact factor: 5.046

4.  3-methylcrotonyl-CoA carboxylase deficiency: clinical, biochemical, enzymatic and molecular studies in 88 individuals.

Authors:  Sarah C Grünert; Martin Stucki; Raphael J Morscher; Terttu Suormala; Celine Bürer; Patricie Burda; Ernst Christensen; Can Ficicioglu; Jürgen Herwig; Stefan Kölker; Dorothea Möslinger; Elisabetta Pasquini; René Santer; K Otfried Schwab; Bridget Wilcken; Brian Fowler; Wyatt W Yue; Matthias R Baumgartner
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

5.  Consanguinity and rare mutations outside of MCCC genes underlie nonspecific phenotypes of MCCD.

Authors:  Peter J Shepard; Bruce A Barshop; Matthias R Baumgartner; John-Bjarne Hansen; Kristen Jepsen; Erin N Smith; Kelly A Frazer
Journal:  Genet Med       Date:  2014-11-06       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.